Global Information would like to present a new market research report, "Emerging Pharmaceutical Blockbusters: 2010s Billion-Dollar Babies" by Decision Resources.
Whether the industry can sustain this model is a matter of debate, but Decision Resources foresees a new crop of future blockbusters reaching the market in 2010. The outlook for these drugs highlights drug and marketplace characteristics that can make big-ticket sales possible.
Questions addressed in this report:
- Decision Resources forecasts that eight drugs that will launch in 2010 have blockbuster sales potential. What are the targets of these agents?
- Type 2 diabetes is a common indication focus for drugs in development - and has consistently been the target of a relatively high number of drugs for which we have predicted blockbuster potential. What are the likely new drug competitors in this marketplace?
- Among the predicted blockbusters expected to launch in 2010 is the first targeted therapeutic vaccine for cancer. How does this agent work?
- We contend that the blockbuster model of success is evolving and that companies should not rely solely on the development of blockbusters. What is the current thinking about the blockbuster model?
Decision Resources, Inc.